Plain-English translation of NCT04902807 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are trying to build a better tool to help doctors diagnose and treat children with primary immune deficiencies—rare genetic conditions where the immune system doesn't work properly. These disorders can cause serious infections, cancer risk, and autoimmune diseases (where the immune system attacks the body's own cells). This study collects biological samples from affected children and healthy controls to understand the disease patterns better and develop a smarter diagnostic and treatment planning tool.
Primary immune deficiencies are unpredictable and affect thousands of children worldwide, but doctors currently struggle to diagnose them early and choose the right treatments. This study aims to create a decision-making tool that can help doctors identify the condition faster and predict which treatments will work best for each child, reducing unnecessary long-term medications and their side effects.
You likely qualify if…
You likely don't qualify if…
If you are a patient with an immune disorder, you will give blood, urine, and stool samples when you join the study and again at a follow-up visit 12 months later. If you are a healthy sibling or control participant, you will provide blood, urine, and stool samples once at the start. All samples will be analyzed to help researchers understand how immune disorders develop and identify patterns that can improve diagnosis and treatment decisions.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
France